FSD Pharma Inc. (NASDAQ: HUGE) AI-Powered Stock Analysis
See how FSD Pharma Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
HUGE●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.09
$0.01(10.10%)
U.S. Market opens in 33h 48m
FSD Pharma Inc. (NASDAQ: HUGE) AI-Powered Stock Analysis
See how FSD Pharma Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerFSD Pharma Inc. (NASDAQ: HUGE) Stock Overall Grade
FSD Pharma Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to FSD Pharma Inc.'s overall NASDAQ stock rating.
Forecast
C+Score
50/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100FSD Pharma Inc. (NASDAQ: HUGE) AI-Powered Stock Analysis
On the NASDAQ, HUGE demonstrates Normal performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NASDAQ: HUGE) Component Analysis Explained
Understand the key factors behind each FSD Pharma Inc. (NASDAQ: HUGE) stock grade, including financials, comparisons, and forecasts.